Psychological Interventions in Children After Road Traffic Accidents or Burns

  • Tell a FriendPrint

Within a randomized controlled design the effects of a brief early psychological intervention (child, parents) after road traffic accidents or burns shall be examined in a sample of 120 children and adolescents (aged 2 to 16 years). During the first seven days after the accident a screening for the risk of developing a posttraumatic stress disorder is conducted to divide the participants into a...

Brief Summary

Official Title: “Psychological Interventions in Children After Road Traffic Accidents or Burns: a Randomized Controlled Study”

Within a randomized controlled design the effects of a brief early psychological intervention (child, parents) after road traffic accidents or burns shall be examined in a sample of 120 children and adolescents (aged 2 to 16 years). During the first seven days after the accident a screening for the risk of developing a posttraumatic stress disorder is conducted to divide the participants into a "high risk" and a "low risk" group. Participants with a low risk are excluded from the intervention study but reassessed six months after their accident to validate the screening instrument. After a baseline assessment within 14 days after the accident participants of the high risk group are randomly assigned to an intervention group (n = 60) or a control group (n = 60). The latter receive standard medical care. Children of the intervention group are provided with a brief age appropriate two-session intervention that includes a detailed reconstruction of the accident, psychoeducation and discussion of helpful coping strategies. Both the control and the intervention group are reassessed by blind raters at 3 and 6 months after the accident.

Assessment of outcome includes measures of posttraumatic stress symptoms, depression, anxiety, behavior, and health-related quality of life.

  • Study Type: Interventional
  • Study Design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Prevention
  • Study Primary Completion Date: November 2012

Intervention(s) in this Clinical Trial

  • Other: Early psychological intervention
    • 3 modules: psychoeducation, reconstruction of the trauma, coping skills

Arms, Groups and Cohorts in this Clinical Trial

  • No Intervention: Control Group
    • standard medical care only
  • Experimental: Intervention group
    • 2 sessions with early psychological interventions

Outcome Measures for this Clinical Trial

Primary Measures

  • Clinician administered PTSD Scale for Children/Adolescents (CAPS-CA) and Child Posttraumatic Stress Disorder Semistructured Interview and Observational Scale (PTSDSSI)
    • Time Frame: Baseline, 3 months, 6 months post intervention
      Safety Issue?: No

Secondary Measures

  • KIDSCREEN-Questionnaire / TAPQOL-Questionnaire (health-related quality of life)
    • Time Frame: Baseline, 3 months, 6 months post intervention
      Safety Issue?: No
  • Child behavior Child Behavior Checklist (CBCL)
    • Time Frame: Baseline, 3 months, 6 months post intervention
      Safety Issue?: No
  • Child Depression Inventory (CDI)
    • Time Frame: Baseline, 3 months, 6 months post intervention
      Safety Issue?: No

Criteria for Participation in this Clinical Trial

Inclusion Criteria:

  • Age 2-16 years
  • Glasgow Coma Scale (GCS) > 8
  • German speaking
  • Burn accident or road traffic accident

Exclusion Criteria:

  • Glasgow Coma Scale (GCS) < 9
  • more than 2 weeks in the Pediatric Intensive Care Unit
  • no command of German
  • previous mental retardation

Gender Eligibility for this Clinical Trial: Both

Minimum Age for this Clinical Trial: 2 Years

Maximum Age for this Clinical Trial: 16 Years

Are Healthy Volunteers Accepted for this Clinical Trial?: No

Clinical Trial Investigator Information

Lead Investigator: University Children's Hospital, Zurich Other

Overall Clinical Trial Officials and Contacts

Markus A Landolt, PhD Principal Investigator University Children's Hospital Zurich, Psychosomatic and Psychiatry  

Overall Contact: Markus A Landolt, PhD +41442667396 markus.landolt@kispi.uzh.ch

Additional Information

Information obtained from ClinicalTrials.gov on February 12, 2012

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT01085370

Study ID Number: PICARTA-B

ClinicalTrials.gov Identifier: NCT01085370

Health Authority: Switzerland: Ethikkommission

  • Tell a FriendPrint

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT01085370